What is PainTEQ?
Founded in 2013 and headquartered in Tampa, Florida, PainTEQ is dedicated to developing innovative solutions for back pain and sacroiliac (SI) joint dysfunction. Their flagship SI joint implant system has been instrumental in over 14,000 procedures, offering patients minimally invasive alternatives to manage chronic pain. This focus positions PainTEQ as a key player in the burgeoning interventional pain management market, aiming to improve patient outcomes through advanced technology.
How much funding has PainTEQ raised?
PainTEQ has raised a total of $35M across 1 funding round:
Debt
$35M
Debt (2023): $35M with participation from Mvolution Partners
What's next for PainTEQ?
With the recent influx of major enterprise-level funding, PainTEQ is poised for accelerated expansion and further innovation in its product pipeline. This strategic investment will likely fuel advancements in their interventional pain management solutions, potentially broadening their market reach and enhancing their proprietary SI joint implant system. The company's trajectory suggests a focus on scaling operations, increasing procedural adoption, and solidifying its position as a leader in addressing debilitating chronic pain.
See full PainTEQ company page
